Related Experiment Video
Updated: Mar 7, 2026

F1FO ATPase Vesicle Preparation and Technique for Performing Patch Clamp Recordings of Submitochondrial Vesicle Membranes
Published on: May 4, 2013
Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1
Danilo Faccenda1, Junji Nakamura2, Giulia Gorini3
1Department of Comparative Biomedical Sciences, The Royal Veterinary College London and UCL Consortium for Mitochondrial Research, Royal College Street, NW1 0TU London, UK; Department of Biology, University of Rome "Tor Vergata," 00133 Rome, Italy.
Abstract:
The ubiquitously expressed ATPase inhibitory factor 1 (IF1) is a mitochondrial protein that blocks the reversal of the F1Fo-ATPsynthase, preventing dissipation of cellular ATP and ischemic damage. IF1 suppresses programmed cell death, enhancing tumor invasion and chemoresistance, and is expressed in various types of human cancers. In this study, we examined its effect on mitochondrial redox balance and apoptotic cristae remodeling, finding that, by maintaining ATP levels, IF1 reduces glutathione (GSH) consumption and inactivation of peroxiredoxin 3 (Prx3) during apoptosis. This correlates with inhibition of metallopeptidase OMA1-mediated processing of the pro-fusion dynamin-related protein optic atrophy 1 (OPA1). Stabilization of OPA1 impedes cristae remodeling and completion of apoptosis. Taken together, these data suggest that IF1 acts on both mitochondrial bioenergetics and structure, is involved in mitochondrial signaling in tumor cells, and may underlie their proliferative capacity.
Insights
ATPase inhibitory factor 1 (IF1) maintains cellular ATP levels, suppressing apoptosis and tumor progression. This mitochondrial protein impacts cancer cell proliferation by regulating redox balance and mitochondrial structure.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- ATPase inhibitory factor 1 (IF1) is a mitochondrial protein that inhibits F1Fo-ATP synthase, preventing ATP depletion during ischemia.
- IF1 is upregulated in various human cancers, where it promotes tumor invasion and chemoresistance by suppressing programmed cell death.
Purpose of the Study:
- To investigate the role of IF1 in regulating mitochondrial redox balance and apoptotic cristae remodeling.
- To elucidate the molecular mechanisms by which IF1 influences cancer cell survival and proliferation.
Main Methods:
- Assessing glutathione (GSH) consumption and peroxiredoxin 3 (Prx3) inactivation during apoptosis.
- Analyzing the processing of optic atrophy 1 (OPA1) by metallopeptidase OMA1.
- Evaluating the impact of IF1 on mitochondrial structure and ATP levels.
Main Results:
- IF1 maintains ATP levels, leading to reduced GSH consumption and Prx3 inactivation during apoptosis.
- IF1 inhibits OMA1-mediated OPA1 processing, stabilizing OPA1 and impeding cristae remodeling.
- Stabilization of OPA1 by IF1 delays the completion of apoptosis and preserves mitochondrial integrity.
Conclusions:
- IF1 influences both mitochondrial bioenergetics and structure, playing a critical role in cancer cell survival.
- IF1's modulation of redox balance and OPA1 stability contributes to its pro-tumorigenic effects.
- IF1 represents a potential therapeutic target for inhibiting cancer cell proliferation and overcoming chemoresistance.
Related Concept Videos
ATP Synthase: Mechanism
The Inner Mitochondrial Membrane
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The ADP/ATP Carrier Protein

